European Union Reworks AI Landscape as Transparency Rules Loom
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
-
Narrado por:
-
De:
But here's the techie twist—innovation's under siege. On December 16th, the Commission unveiled a package to simplify medical device regs under the AI Act, part of the Safe Hearts Plan targeting cardiovascular killers with AI-powered prediction tools and the European Medicines Agency's oversight. Yet, whispers from Greenberg Traurig reports swirl: the EU's eyeing a one-year delay on high-risk AI rules, originally due August 2027, amid pleas from U.S. tech giants and Member States. Technical standards aren't ripe, they say, in this Digital Omnibus push to slash compliance costs by 25% for firms and 35% for SMEs. Streamlined cybersecurity reporting, GDPR tweaks, and data labs to fuel European AI startups—it's a Competitiveness Compass pivot, but critics howl it dilutes safeguards.
Globally, ripples hit hard. On December 8th, the EU and Canada inked a Memorandum of Understanding during their Digital Partnership Council kickoff, pledging joint standards, skills training, and trustworthy AI trade. Meanwhile, across the Atlantic, President Trump's December 11th Executive Order rails against state-level chaos—over 1,000 U.S. bills in 2025—pushing federal preemption via DOJ task forces and FCC probes to shield innovation from "ideological bias." The UK's ICO, with its June AI and Biometrics Strategy, and France's CNIL guidelines on GDPR for AI training, echo this frenzy.
Ponder this, listeners: as AI blurs reality in our feeds, will Europe's balancing act—risk tiers from prohibited biometric surveillance to voluntary general-purpose codes—export trust or stifle the next GPT leap? The Act's phased rollout through 2027 demands data protection by design, yet device makers flee overlapping regs, per BioWorld insights. We're at a nexus: Brussels' rigor versus Silicon Valley's speed.
Thank you for tuning in, and please subscribe for more deep dives. This has been a Quiet Please production, for more check out quietplease.ai.
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
This content was created in partnership and with the help of Artificial Intelligence AI
Todavía no hay opiniones